Osteoporosis Drugs Flashcards
bisphosphonates (oral)
- inhibit osteoclast mediated bone resorption → increases bone density
- Example: Alendronate
- Primary drug
- Contraindications
- drug allergy, hypocalcemia, esophageal dysfunction, and the inability to sit or stand upright for at least 30 minutes
- Side effects
- headache, GI upset, and joint pain.
- Rare case reports of osteonecrosis of the jaw
- Given in early morning before other drugs
bisphosphonates (IV)
- Example: Zoledronic Acid
- Treatment: IV: 5 mg once every 12 months
Adverse effects can include:
- acute phase reaction post-infusion, hair loss, hypotension, dehydration, GI effects, anemia, headache, joint pain, renal insufficiency, hypocalcemia, -hypersensitivity reactions, case reports of osteonecrosis of jaw & bone fractures (others exist)
For those who:
- Have a high fracture risk
- have esophageal disorders (can’t tolerate oral meds)
- gastrointestinal intolerance to oral bisphosphonates
- history of Roux-en-Y gastric bypass
- an inability to follow the dosing requirements of oral bisphosphonates, including - an inability to sit upright for 30 to 60 minutes and/or to swallow a pill
- Can tolerate an IV administration annually
Raloxifene
- selective estrogen receptor modulators (SERMs)
- stimulate the estrogen receptors on bones and increases bone density
- Raloxifene: Primarily used for the treatment of prevention of postmenopausal osteoporosis
- Contraindications - known allergies to drugs, pregnancy, hypokalemia, kidney impairment, and past blood clot issues
- Side effects - hot flashes and leg cramps. They can also increase the risk of blood clots and leukopenia (low WBC count)
Forteo
- SERM
- Only drug available that acts by stimulating bone formation
- Derivative of parathyroid hormone that works to modulate the body’s calcium and PO4 metabolism
- Used for a small subset of individuals at high risk for osteoporosis
- Rarely used
- Contraindicated for those with a known drug allergy
- Adverse effects
- hypercalcemia, hypotension, chest pain, renal stones, GI effects, and joint pains (among others)
Prolia (denosumab)
- SERM
- Mechanism of action: Monoclonal antibody that blocks osteoclast activation and prevents bone resorption
- Sub q injection given every 6 months
- Used for those at high risk for osteoporosis that are unable to tolerate first line therapies
- Contraindications: hypocalcemia, allergy to drug, kidney impairment/failure and current infection
- Adverse effects include: edema, hypocalcemia, GI upset, anemia, fatigue, joint pain, increased risk of infection, case reports of osteonecrosis of the jaw, among others